TLR9 and diabetes mellitus: However, there was no particular resistance to beta cell death in Tlr9−/− NOD mice, as diabetes onset was similar to the onset in their Tlr9+/+ NOD counterparts after STZ treatment, both at high dose and multiple low doses (Fig. 3a, b).